We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Hematology Testing Instrument Market Driven by Growing Demand for Preventive Diagnosis and Treatment Monitoring

By LabMedica International staff writers
Posted on 26 Aug 2021
Print article
Illustration
Illustration
The global hematology testing instrument market is witnessing high growth due to technological advances in disease diagnosis and rise in demand for preventive diagnosis and treatment monitoring.

These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider.

Hematology involves the study of blood, in particular how blood can affect overall health. Used in different settings, hematology instruments can do blood count, detect proteins or enzymes, and help to diagnose illnesses or genetic defects. Hematology tests can evaluate a number of blood conditions including infection, anemia, inflammation, hemophilia, blood-clotting disorders, leukemia, and the body’s response to chemotherapy treatments. Tests could be routine and regular, or these may be used to diagnose serious conditions in urgent situations.

Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detecting small cell populations to diagnose rare blood conditions, which require less labor, rapid result, and easy-to-use analyzers. Current technologies include automation of hematology analyzers, electrical impedance, flow cytometry, and fluorescent flow. The combination of these technologies has increased the yield and productivity of test results. Test volume i.e., number of tests performed, is projected to increase owing to technological advances in disease diagnosis and rise in demand for preventive diagnosis and treatment monitoring. This will also augment the demand for hematology analyzers with high throughput. Such technological revolutions in hematology testing are expected to propel the market growth during the forecast period.

However, technological advancements in blood testing instruments carry a heavy price tag. A number of laboratories cannot afford highly priced instruments. Therefore, there is a need of low-volume laboratory analyzers, which are cost-effective and easy-to-use. The high cost of instruments can increase testing cost, which can restrain the growth of the global hematology diagnostic market during the forecast period.

Geographically, North America is projected to dominate the global hematology diagnostic market during the forecast period. This can be attributed to the high average selling price of automated hematology analyzers, rise in demand among surgeons for technologically-advanced diagnostic instruments with enhanced specificity & precision, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region.

Related Links:
Transparency Market Research

Gold Supplier
Fully Automated ELISA Workstation
EUROLabWorkstation ELISA
New
Vented Safety Enclosures
VSE Balance Enclosures
New
Gold Supplier
Desktop Urine Analyzer
MONOZYME TX2000
New
Fluorescence Immunoassay Analyzer
FIATEST

Print article

Channels

Clinical Chem.

view channel
Image: Illustration is of the Vertical Auto Profile (VAP) Lipid test with clear demarcation of the different lipoprotein classes and subclasses. (Photo courtesy of VAP Diagnostics Laboratory)

Lipoprotein(a) Concentrations Correlate With LDL-C in Diabetic Children

Cardiovascular disease (CVD) is a significant cause of mortality in those with diabetes. Increased apolipoprotein B (apoB) and low-density lipoprotein cholesterol (LDL-C) have been shown in pediatric patients... Read more

Molecular Diagnostics

view channel
Image: Model of the PD-1 (Programmed cell death protein 1) protein. Only a subset of recurrent glioblastomas respond to anti-PD-1 immunotherapy (Photo courtesy of Wikimedia Commons)

Biomarker Predicts Potential Benefit of Checkpoint Inhibitor Therapy for Brain Cancer Patients

A phosphorylated form of ERK (extracellular signal-regulated kinase) protein has been identified as a biomarker that may be used to predict which brain cancer patients might benefit from checkpoint inhibitor... Read more

Hematology

view channel
Image: The UniCel DxH 800 Coulter Cellular Analysis System (Photo courtesy of Beckman Coulter)

Monocyte Distribution Width Predicts Sepsis in Critically Ill Patients

Sepsis has been reported as a major cause of increased morbidity, length of stay and mortality among patients hospitalized in Intensive Care Units (ICUs) for any cause. The survival of patients developing... Read more

Immunology

view channel
Image: Procartaplex Immunoassays Kits are based on the principles of a sandwich ELISA, using two highly specific antibodies binding to different epitopes of one protein to quantitate all protein targets simultaneously (Photo courtesy of Thermo Fisher Scientific)

Assay Developed for Patient-Specific Monitoring and Treatment for Ovarian Cancer

Tumors can influence peripheral immune macroenvironment, thereby creating opportunities for non-invasive serum/plasma immunobiomarkers for immunostratification and immunotherapy designing.... Read more

Microbiology

view channel
Image: Clinical metagenomics (CMg) using nanopore sequencing (Photo courtesy of Oxford Nanopore Technologies)

Same Day Test Identifies Secondary Infections in COVID-19 Patients

The intensive care unit (ICU) is a dynamic environment with frequent staff-patient contact for invasive monitoring, interventions and personal care that together introduce the risk of secondary or nosocomial... Read more

Pathology

view channel
Image: The Ventana BenchMark Ultra autostainer is for cancer diagnostics with automation and the test menu include IHC, ISH, and FITC tests (Photo courtesy of Ventana Medical System)

Specific Biomarker Investigated for Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression and comprises a heterogeneous... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.